Comparison
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 vs 3q26q28 Deletion Syndrome C6010434
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Endogenous Maternal Derived Androgen and 3q26q28 Deletion Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
A condition where hormones from the mother cross the placenta and cause atypical development in an XX fetus. It is present at birth. Management involves pediatric specialists and may include hormone therapy.
3q26q28 Deletion Syndrome C6010434
A genetic condition involving deletion of part of chromosome 3q26q28, typically causing developmental delays, growth issues, and multiple congenital differences.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Variable
3q26q28 Deletion Syndrome C6010434
Variable
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
severe
3q26q28 Deletion Syndrome C6010434
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Chronic
3q26q28 Deletion Syndrome C6010434
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
No
3q26q28 Deletion Syndrome C6010434
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
reproductive
3q26q28 Deletion Syndrome C6010434
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
endocrine
3q26q28 Deletion Syndrome C6010434
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-endogenous-maternal-derived-androgen-C5679875 and 3q26q28-deletion-syndrome-C6010434 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 3q26q28 Deletion Syndrome C6010434 | Discriminating power |
|---|---|---|---|
| Atypical genital development | Present at birth in an XX fetus after maternal androgen crosses the placenta. | Not established as a defining feature from the supplied description. | High |
| Developmental delay | Not described as a core feature in the source data. | Typically associated with developmental delay. | High |
| Growth and congenital differences | Primarily framed as a reproductive and endocrine condition. | Typically includes growth issues and multiple congenital differences. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 when
XX newborn with atypical sex development
Source links maternal-derived androgen exposure to atypical XX development.
Moderate
Suspected maternal androgen source
Endogenous maternal hormone exposure is the stated mechanism.
Moderate
Endocrine rather than chromosomal pattern
Category is endocrine and body system is reproductive.
Low
Choose 3q26q28 Deletion Syndrome C6010434 when
Developmental delay with congenital anomalies
These features are described for the deletion syndrome.
Moderate
Suspected chromosomal deletion
The condition is defined by deletion of chromosome 3q26q28.
High
Multisystem congenital presentation
Source describes multiple congenital differences rather than isolated DSD.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 3q26q28 Deletion Syndrome C6010434 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XX is implied by the condition name. | Sex-chromosome result is not established by the source. | A 46,XX result does not exclude either condition. |
| Chromosomal microarray | A 3q26q28 deletion is not part of the stated mechanism. | Deletion involving 3q26q28 supports this diagnosis. | Genetic confirmation should be interpreted by a genetics clinician. |
| Androgen evaluation | Maternal or fetal androgen context is clinically relevant. | Androgen abnormality is not established. | Abnormal hormones are findings, not a complete diagnosis. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
- Outcome
- Chronic and labeled severe, but individual outcome is not established.
- Factors
- Timing of recognition, endocrine findings, and specialist management may matter.
3q26q28 Deletion Syndrome C6010434
- Outcome
- Chronic and labeled moderate, with variable developmental and growth effects.
- Factors
- Extent of deletion and associated congenital differences may influence course.
Time frame: Lifelong, with onset described as variable for both.
Prognosis should be individualized; comparative survival data are not supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Reproductive complications | Atypical sex development may require specialist management. Reproductive effects are not established in the source. Do not assume fertility outcomes without evaluation. |
| Neurodevelopmental complications | Not established from the supplied description. Developmental delay is typically described. Severity and specific deficits are not quantified here. |
| Growth complications | Growth effects are not established. Growth issues are typically described. Exact measurements or cutoffs are not supplied. |
Patient education highlights
- HighSpecialist care
Both conditions need individualized pediatric, endocrine, or genetics assessment.
- HighDiagnosis versus finding
An abnormal test or physical finding does not by itself establish the full diagnosis.
- MediumUncertain details
Prevalence, exact laboratory cutoffs, mortality, and treatment doses are not established here.